Find Reports
Select Report Type
Reimbursement Review
Displaying 726 - 750 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Guanfacine hydrochloride | Intuniv XR | Guanfacine hydrochloride | Attention-deficit/hyperactivity disorder (ADHD) | Do not list | Complete | SR0349-000 | |||
| Phleum pratense | Grastek | Phleum pratense | Allergic rhinitis | Do not list | Complete | SR0352-000 | |||
| Abraxane for Metastatic Pancre... | Abraxane | Nab-paclitaxel | Metastatic Pancreatic Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0037-000 | |||
| Zaltrap for Metastatic Colorec... | Zaltrap | Aflibercept | Metastatic Colorectal Cancer | Do not reimburse | Complete | PC0035-000 | |||
| Dolutegravir | Tivicay | Dolutegravir | HIV infection | List | Complete | SR0357-000 | |||
| Fluticasone furoate /vilantero... | Breo Ellipta | Fluticasone furoate /vilanterol | Chronic Obstructive Pulmonary Disease (COPD) | List with criteria/condition | Complete | SR0358-000 | |||
| Sofosbuvir | Sovaldi | Sofosbuvir | Hepatitis C, chronic | List with criteria/condition | Complete | SR0356-000 | |||
| Pomalyst for Multiple Myeloma ... | Pomalyst | Pomalidomide | Multiple Myeloma | Reimburse with clinical criteria and/or conditions | Complete | PC0036-000 | |||
| Riociguat | Adempas | Riociguat | Chronic thromboembolic pulmonary hypertension | List with criteria/condition | Complete | SR0353-000 | |||
| Golimumab | Simponi I.V. | Golimumab | Arthritis, rheumatoid | List with criteria/condition | Complete | SR0351-000 | |||
| Saxagliptin + Metformin | Komboglyze | Saxagliptin + metformin | Diabetes Mellitus, type 2 | List with criteria/condition | Complete | SR0348-000 | |||
| Simeprevir | Galexos | Simeprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SR0347-000 | |||
| Teriflunomide | Aubagio | Teriflunomide | Multiple sclerosis, relapsing-remitting | Do not list at the submitted price | Complete | SR0350-000 | |||
| OnabotulinumtoxinA | Botox | OnabotulinumtoxinA | Migraine | Do not list | Complete | SR0345-000 | |||
| Rotigotine | Neupro | Rotigotine | Parkinson's disease | Do not list | Complete | SR0344-000 | |||
| Giotrif for Advanced Non Small... | Giotrif | Afatinib | Advanced or Metastatic Non-Small Cell Lung Cancer | Reimburse | Complete | PC0032-000 | |||
| Stivarga for Gastrointestinal ... | Stivarga (GIST) | Regorafenib | Gastrointestinal Stromal Tumour | Reimburse with clinical criteria and/or conditions | Complete | PC0034-000 | |||
| Eplerenone | Inspra | Eplerenone | Heart failure, NYHA class II | Do not list at the submitted price | Complete | SR0342-000 | |||
| Aclidinium bromide | Tudorza Genuair | Aclidinium bromide | Chronic Obstructive Pulmonary Disease | List with criteria/condition | Complete | SR0346-000 | |||
| Rivaroxaban | Xarelto | Rivaroxaban | Venous thromboembolic events, pulmonary embolism | List with criteria/condition | Complete | SR0327-000 | |||
| Tocilizumab | Actemra | Tocilizumab | Arthritis, polyarticular juvenile idiopathic | List with criteria/condition | Complete | SR0343-000 | |||
| Golimumab | Simponi | Golimumab | Ulcerative colitis | Do not list at the submitted price | Complete | SR0341-000 | |||
| Trisenox for Acute Promyelocyt... | Trisenox | Arsenic Trioxide | Acute Promyelocytic Leukemia | Reimburse | Complete | PC0033-000 | |||
| Ingenol mebutate | Picato | Ingenol mebutate | Actinic keratosis | Do not list | Complete | SR0330-000 | |||
| Erbitux for Metastatic Colorec... | Erbitux | Cetuximab | Metastatic Colorectal Cancer | Do not reimburse | Complete | PC0031-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 726 - 750 of 2132
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| pralsetinib | Reimbursement Review | Complete | PC0283-000 | ||||
| Community Supports for People with Tuberculosis | Health Technology Review | Technology Review | Completed | HC0051-000 | |||
| nivolumab | Reimbursement Review | Complete | PC0272-000 | ||||
| Transition from alteplase (tPA) to tenecteplase (TNK) for thrombolysis for acute ischemic stroke | Health Technology Review | Policy Insight | In Progress | CY0015-000 | |||
| abemaciclib | Reimbursement Review | Complete | PC0282-000 | ||||
| pembrolizumab and lenvatinib | Reimbursement Review | Complete | PC0288-000 | ||||
| pembrolizumab | Reimbursement Review | Complete | PC0279-000 | ||||
| semaglutide | Reimbursement Review | Complete | SR0725-000 | ||||
| atezolizumab | Reimbursement Review | Complete | PC0277-000 | ||||
| Bevacizumab for the Treatment of Patients with Brain Radionecrosis | Health Technology Review | Rapid Review | Completed | RC1465-000 | |||
| Subtypes of Post-COVID-19 Condition | Health Technology Review | Technology Review | Completed | HC0035-000 | |||
| NSCLC without actionable oncogenic alterations | Reimbursement Review | Provisional Funding Algorithm | Completed | PH0015-000 | |||
| Oseltamivir for the Prevention of Influenza in Residents of Long-Term Care Facilities | Health Technology Review | Rapid Review | Completed | RC1464-000 | |||
| asciminib | Reimbursement Review | Complete | PC0275-000 | ||||
| dostarlimab | Reimbursement Review | Complete | PC0263-000 | ||||
| Octreotide Long-Acting Release and Everolimus for Recurrent Meningiomas | Health Technology Review | Rapid Review | Completed | RC1462-000 | |||
| Body Mass Index as a Measure of Obesity and Cut-off for Surgical Eligibility | Health Technology Review | Technology Review | Completed | HC0048-000 | |||
| faricimab | Reimbursement Review | Complete | SR0719-000 | ||||
| Multiple Myeloma (MM) | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0014-000 | |||
| Treatment Options for VEXAS Syndrome | Health Technology Review | Rapid Review | Completed | RC1460-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 32 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Intravenous Iron Preparations for Patients Undergoing Elective Surgery: A 2022 Update | Health Technology Review | Rapid Review | Completed | RC1457-000 | |||
| Peer Support Programs for Youth Mental Health | Health Technology Review | Health Technology Assessment | Completed | HT0036-000 | |||
| nusinersen | Reimbursement Review | Complete | SR0713-000 | ||||
| Raltitrexed in patients with dihydropyrimidine dehydrogenase (DPD) deficiency | Health Technology Review | Reference List | Completed | RC1463-000 |